Activation of the peripheral endocannabinoid system in human obesity - Wikidata - awgldk - TriplyDB

Activation of the peripheral endocannabinoid system in human obesity

Activation of the peripheral endocannabinoid system in human obesity

http://www.wikidata.org/entity/Q24655297

about

Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Endocrine disrupters as obesogens The endocannabinoid system as an emerging target of pharmacotherapy The thrifty lipids: endocannabinoids and the neural control of energy conservation Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes The role of metabolic syndrome in heart failure The endocannabinoid system: directing eating behavior and macronutrient metabolism Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship Vagus nerve stimulation reduces body weight and fat mass in rats Endocannabinoids, blood pressure and the human heart.The endocannabinoid system: a new pharmacological target for obesity treatment?Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data Dysregulation of the endocannabinoid system in obesity.Identification of endocannabinoids and related compounds in human fat cells.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis Biomarkers of endocannabinoid system activation in severe obesity Meta-analyses between 18 candidate genetic markers and overweight/obesity Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial.Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity.A covering method for detecting genetic associations between rare variants and common phenotypes.The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.The endocannabinoid system: potential for reducing cardiometabolic risk Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.The endocannabinoid system links gut microbiota to adipogenesis Diagnosing impaired glucose tolerance using direct infusion mass spectrometry of blood plasma.Toxicity of weight loss agents The endocrinology of exercise.Endocannabinoids measurement in human saliva as potential biomarker of obesity.Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.New insights on the role of the endocannabinoid system in the regulation of energy balance.

P2860

Q21090979-214503E3-F035-485D-959C-AF490A813AF5 Q21132308-8AA7BB37-2DE9-4A8B-8089-0C49E218FDAA Q24647272-545DA6CB-47A1-4127-852B-3956157D9695 Q24648473-57DAB1B8-252A-4602-81DC-57B5D7CB90EB Q26996134-30D4B174-71E8-4C88-A72E-8FA0D30F6351 Q27001165-BCED9102-94CB-4F60-9AE0-51FB35BDFC2D Q28078897-58A6C037-5B4E-491A-900F-A049E22DC70E Q28085668-E97416DD-9D00-4CD4-B8BE-0A0DD553AAA0 Q28086830-AC9D67FD-5E29-4734-9471-280A9B23E4BD Q28475155-E82267FB-0C1E-4C59-909F-98C6EF6B838D Q28484122-068CFE7F-1941-4156-8C77-1DBAD03F797C Q30368944-75F0ADB0-2D96-4192-A084-CFD8D196EB85 Q30377157-B7021C25-60C2-4274-83C4-2CE21D47C6C4 Q31116375-5723A503-280D-4E77-A938-9C66E24BC5DF Q33345484-1B990E6B-1692-428E-8583-19A29D282960 Q33437059-822EE3DD-0932-462D-96A1-6D7A266B3492 Q33464957-9D11F5E2-63CE-4EE3-A046-AC515E1B7EA8 Q33526312-9CDFB29A-9F3A-4A90-BFD1-D6FCF6D8380B Q33559160-3CF396E8-2926-4065-B510-61A7237A89B2 Q33600484-C655EC71-8068-4FBC-8781-BE6201D016C5 Q33631964-984B2E18-3CD6-4EF5-B5E2-FC3AAE6E54BB Q33694013-A967907D-9EC2-4121-86E9-51275660E379 Q33698241-110E037C-9DEB-48DF-AB51-82CED9124F12 Q33728635-CA62BF6E-B9A2-4938-927C-D0EA8BC09BAD Q33822403-45F9FCEC-D460-4DF9-8F57-FA0A47661C68 Q33846570-A0B8E4F4-76AC-4C9B-A82D-D3304DEC1390 Q33952044-E24BC141-40AC-4B68-8941-842605B1CC95 Q33993080-671F5A9F-7054-4DF7-A47D-744AA0B343EA Q33999727-F2972F77-8B4F-4C44-8A82-ACD3CF3D5BC3 Q34013800-2F0C9B2B-0689-418C-A68C-12EDEB9C557B Q34015624-A6B2332E-FADF-4A55-AA81-3169572DB86D Q34019573-6C36388E-132E-401D-97EB-441F9F833FF2 Q34028741-EC7A5744-EC7A-4307-A7E3-20E70A5B2091 Q34078880-11AB4777-6A95-4F6B-A136-557FE9B946A6 Q34155246-73016762-3DE2-4C85-B54B-A219950C4426 Q34255825-D7E81CC0-43FD-473F-AB9B-8EAAAA7C1AF5 Q34332068-5E328179-255A-4C31-9978-1BEACC2C7B54 Q34364857-44B74C43-5A86-4995-BBD3-2B190488A7D1 Q34369293-B3C0B1E2-5909-4E5E-8692-D702EBCDD635 Q34494301-C4E5C3AA-1587-4D8B-A6BD-46A675BCB86D

P2860

Activation of the peripheral endocannabinoid system in human obesity

http://www.wikidata.org/entity/Q24655297

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Activation of the peripheral endocannabinoid system in human obesity

@ast

Activation of the peripheral endocannabinoid system in human obesity

@en

Activation of the peripheral endocannabinoid system in human obesity

@nl

type

label

Activation of the peripheral endocannabinoid system in human obesity

@ast

Activation of the peripheral endocannabinoid system in human obesity

@en

Activation of the peripheral endocannabinoid system in human obesity

@nl

prefLabel

Activation of the peripheral endocannabinoid system in human obesity

@ast

Activation of the peripheral endocannabinoid system in human obesity

@en

Activation of the peripheral endocannabinoid system in human obesity

@nl

P1433

Q24655297-9B604AF8-8D9E-42E5-BC9A-62C9F4D2E3C2

P1476

Q24655297-5E688724-C5A8-414B-8163-53C28D4E6469

P2093

Q24655297-4162A835-8A98-4AA0-BE59-1DFDF5D2A4BC

Q24655297-4B9E1B87-B72F-4793-A560-EC55601659A4

Q24655297-66A5AD65-C857-4F41-9D1F-9EC2590FC67A

Q24655297-85FAC5C3-47C9-4DEC-8EFD-1783E385E5D5

Q24655297-972B1233-4394-4605-A343-A66FC70ED706

Q24655297-AD0A7295-3741-48BE-9539-AF473F469CC8

Q24655297-B9C0A59D-960F-47AC-ADE8-AAFD471AD5D4

Q24655297-C2633D7A-D708-4C14-AB10-8016CEED8A4D

Q24655297-CAEC3504-166A-4B94-818D-264EFBADC155

Q24655297-CE7F2125-DDBE-4721-B2DE-0C784D678E3C

P2860

Q24655297-0EACCBFF-2286-4A01-9B95-7915433961B9

Q24655297-0F1913D3-B085-4F89-8E48-67AD0D660EB7

Q24655297-1FC4B0F7-336D-4923-AF03-EC89DD01B80B

Q24655297-252848F4-A657-4512-84DC-64BD0809F926

Q24655297-2594CD75-61C0-4BB0-A815-0DD813F91DCD

Q24655297-270A464B-7478-4DD7-BCA8-8E20AFE6C2DC

Q24655297-2BA82EA3-EAEF-4A97-847E-ACDB9B02D62E

Q24655297-2C130D81-BEB7-4A25-8792-21060C2AC19E

Q24655297-31DD900D-3210-44A6-B381-0D10B5C1DB7C

Q24655297-3FD0FF97-D907-44EB-B0DD-71AB6C72874F

P304

Q24655297-591E6017-2C99-4CE0-8522-2C8A10CD0182

P31

Q24655297-4D20CBE7-C699-4B26-8FEA-445825FC1EBD

P3181

Q24655297-F8AD1DDB-F559-4D30-B2B3-270167E8A8F5

P356

Q24655297-446178D4-04F3-48F5-8A71-434DD9C8A67B

P407

Q24655297-7FB1BCDE-C591-4A95-9106-95A5683EB043

P433

Q24655297-680D6525-39A3-4070-BF9C-A3D9D7CFA0EB

P478

Q24655297-DE16D3EB-7D53-4801-8B7E-5CB368859863

P50

Q24655297-91CC7FC2-3E62-4AE1-949B-DDAF8FC374E6

P577

Q24655297-1B5F3A4E-A63B-4EB9-9C8D-63A2216C4E1E

P5875

Q24655297-9C34062A-3828-4109-A3A8-4A1C6E2C3B79

P698

Q24655297-1A212C38-A835-42D8-8650-96FEC79A457C

P921

Q24655297-518C4186-DA78-4131-932A-00C1B5F2A723

Q24655297-BE034ADD-AF47-4F75-BFE6-95DB8231766A

P932

Q24655297-6C3FDC1F-C008-489B-9A59-F1C6704C21AA

P3181

P356

DIABETES.54.10.2838

P1433

P1476

Activation of the peripheral endocannabinoid system in human obesity

@en

P2093

Arya M Sharma

http://www.w3.org/2001/XMLSchema#string

Jana Böhnke

http://www.w3.org/2001/XMLSchema#string

Jens Jordan

http://www.w3.org/2001/XMLSchema#string

Judy Harvey-White

http://www.w3.org/2001/XMLSchema#string

Jürgen Janke

http://www.w3.org/2001/XMLSchema#string

Kerstin Gorzelniak

http://www.w3.org/2001/XMLSchema#string

Mareike Feldpausch

http://www.w3.org/2001/XMLSchema#string

Pál Pacher

http://www.w3.org/2001/XMLSchema#string

Stefan Engeli

http://www.w3.org/2001/XMLSchema#string

Sándor Bátkai

http://www.w3.org/2001/XMLSchema#string

P2860

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Leptin-regulated endocannabinoids are involved in maintaining food intake

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

The molecular logic of endocannabinoid signalling

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

Tetrahydrocannabinol and endocannabinoids in feeding and appetite.

P304

2838-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3573809

http://www.w3.org/2001/XMLSchema#string

P356

10.2337/DIABETES.54.10.2838

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Friedrich C. Luft

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7578789

http://www.w3.org/2001/XMLSchema#string

P698

16186383

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoid system

P932

2228268

http://www.w3.org/2001/XMLSchema#string